Skip to main content


U.S. flag
      An official website of the United States government
              Here’s how you know
        Here’s how you knowDot gov**Official websites use .gov**
                 A **.gov** website belongs to an official government organization in the United States.
                  HTTPS**Secure .gov websites use HTTPS**
                 A **lock** (A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. 
  Menu Close
          HHS Search (ash)
    Search
        








  
  
    

  
      

                                      About HHS
    
                        
                              
      
      
      Programs & Services
    
                        
                              
      
      
      Grants & Contracts
    
                        
                              
      
      
      Laws & Regulations                  
Office of the Assistant Secretary for Health
  About OASH
    
                        
                                            
      
      
      Public Health Offices
    
                        
                                            
      
      
      Advisory Committees

              

    



Breadcrumb
    HHS
                              ASH Home
                              Office of Science and Medicine
                              InnovationX
                              KidneyX


    

    

    Navigate to:
  Office of Science and Medicine
    
                                                  
                                                                  
            
      
      
      
      Chief Medical Officer
                                            
            
            Initiative on Substance Exposure in the Mother-Infant Dyad
    
                                                  
                                                                                        
                          
      
      
      
      InnovationX
                                            
            
            Covid-19 Data Driven Innovation
    
                                                                
                                                                  
            
      
      
      
      Human-Centered Design
                          
            
            Clinical Response through Emerging Technology (CRET)
    
                                                  
                                            
            
      
      
      
      Sickle Cell Disease
    
                                                  
                                                                  
                          
      
      
      
      KidneyX
    
                                                                
                                                                  
            
      
      
      
      Lyme Innovation
                          
            
            Lyme Innovation: Real-World Impact
    
                                                  
                                            
            
      
      
      
      LymeX
    
                                                  
                                            
            
      
      
      
      PandemicX
    
                                                                
                                                                  
            
      
      
      
      Vector-Borne Disease National Strategy
                          
            
            Public Engagement
    
                                                  
                                            
            
      
      
      
      The Kay Hagan Tick Act
    
                                    
                                            
            
      
      
      
      LeadershipText resize icon

                    




KidneyX








  
  
    

  
      





KidneyX


The Kidney Innovation Accelerator (KidneyX) is a public-private partnership between the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases. Through a series of prize competitions, KidneyX is stimulating and accelerating innovation. KidneyX brings together people with kidney diseases, researchers, innovators, and investors to transform the future of kidney treatment and care.

KidneyX at a glance:

Delivered six competitions in its first five years
	Awarded over $17 million to KidneyX winners in 26 different states

2024

	KidneyX celebrates five years of impact and continues driving innovation with more prize competitions.
	June 2023

	KidneyX awards $9.2 million in prizes across eight winners in the Artificial Kidney Prize Phase 2.
	November 2021

	KidneyX awards $3.9 million in prizes across six winners in the Artificial Kidney Prize Phase 1.
	April 2021

	KidneyX awards $300,000 in prizes across 15 winners in the COVID-19 Kidney Care Challenge.
	July 2020

	KidneyX awards $3 million in prizes across six winners in Redesign Dialysis Phase 2.
	March 2020

	KidneyX awards $70,000 in prizes across 25 winners in the Patient Innovator Challenge.
	April 2019

	KidneyX awards $1.125 million in prizes across 15 winners in Redesign Dialysis Phase 1.
	April 26, 2018

	HHS and ASN announce the Kidney Innovation Accelerator.
	February 2017

	The U.S. Department of Veterans Affairs and ASN host the inaugural Kidney Innovation Summit.
	June 2016

	The U.S. Department of Veterans Affairs and ASN host the inaugural Kidney Innovation Summit.Strategic Priorities

KidneyX is catalyzing change through three strategic priorities:

**Support innovation:**KidneyX prize competitions shape and support disruptive approaches to kidney care.
	**Advance solutions:**KidneyX promotes the innovators and innovations that improve quality of life for people with kidney diseases.
	**Build community:**KidneyX creates an ecosystem to strengthen and sustain collaborations among all innovators.A Call for Innovators and Breakthrough Solutions

KidneyX accelerates innovation in the prevention, diagnosis, and treatment of kidney diseases through prize competitions. The most ambitious prize to date is the Artificial Kidney Prize to fast-track the development of artificial kidneys toward human clinical trials. The partnership invites people with kidney diseases and their care partners, researchers, innovators, companies, and investors to accelerate the development of breakthrough innovations for the 850 million people worldwide with kidney diseases.

To learn more about KidneyX prize competitions and how to get involved, visit KidneyX.org.
                        Artificial Kidney Prize Phase 2
    *August 2022*—Artificial Kidney Prize Phase 2 launches, inviting submissions focused on either developing prototype bioartificial kidneys or a new tool or component that can help enable the development of bioartificial kidneys. The two-track competition awards $9.2 million in prizes across eight winners.
      COVID-19 Kidney Care Challenge
    *November 2020*—COVID-19 Kidney Care Challenge launches, seeking solutions that reduce the transmission of coronavirus among people with kidney diseases and/or reduce the risk of kidney damage among people who contract the virus. The two-round challenge awards $300,000 in prizes across 15 winners.
      Artificial Kidney Prize Phase 1
    *October 2020*—Artificial Kidney Prize Phase 1 launches, seeking solutions that enable and advance the functionality, effectiveness, and/or reliability of artificial kidneys. The first phase awards $3.9 million in prizes across six winners.
      Redesign Dialysis Phase 2
    *November 2019*—Redesign Dialysis Phase 2 launches, seeking prototype solutions, or components of solutions, that could replicate normal kidney functions or improve dialysis access. The second phase awards $3 million in prizes across six winners.
      Patient Innovator Challenge
    *July 2019*—Patient Innovator Challenge launches, inviting solvers to submit ideas for improving therapeutic options and quality of life for people with kidney diseases. The two-category challenge awards $70,000 in prizes across 25 winners.
      Redesign Dialysis Phase 1
    *October 2018*—Redesign Dialysis Phase 1 launches, asking participants to design solutions or components of solutions that can replicate normal kidney functions and improve quality of life for people with kidney diseases. The first phase awards $1.125 million in prizes across 15 winners.
                        The Approach

HHS serves as a scout, convener, connector, and accelerator to move transformative kidney-care solutions to market, KidneyX connects its solver community and American innovators with interdisciplinary networks, government data stewards, and resources for technology transfer from lab to market. The guiding KidneyX principles are:

**Achievable:** Ground in scientifically driven technology development.
	**Additive:** Address barriers to innovation that are not already addressed by the public or private sectors.
	**Catalytic:** Reduce risks to incentivize further investments in kidney innovation.
	**Collaborative:** Foster multidisciplinary and multisector teamwork.
	**Mission-driven:** Ensure all product development is human-centered.
	**Urgent:** Create a sense of urgency to meet the needs of people with kidney diseases.Stay Informed

Challenge.gov, home of U.S. open innovation that posts KidneyX challenges
	Follow KidneyX on X (formerly Twitter) at @KidneyX for social media updates
	KidneyX.org for news, events, and additional information

                    
  


Content created by Assistant Secretary for Health (ASH) Content last reviewed March 7, 2024Back to top
    Contact HHS
    
                        
                                            
      
      
      Careers
    
                        
                                            
      
      
      HHS FAQs
    
                        
                                            
      
      
      Nondiscrimination NoticeHHS Archive
    
                        
                                            
      
      
      Accessibility Statement
    
                        
                                            
      
      
      Privacy Policy
    
                        
                                            
      
      
      Viewers & PlayersBudget/Performance
    
                        
                                            
      
      
      Inspector General
    
                        
                                            
      
      
      Web Site Disclaimers
    
                        
                                            
      
      
      EEO/No Fear ActFOIA
    
                        
                                            
      
      
      The White House
    
                        
                                            
      
      
      USA.gov
    
                        
                                            
      
      
      Vulnerability Disclosure Policy
        Sign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases.

Sign Up
  HHS Headquarters
          200 Independence Avenue, S.W.
                  Washington, D.C. 20201
                  Toll Free Call Center: 1-877-696-6775​Disclaimer Policy: Links with this icon () mean that you are leaving the HHS website.
              The Department of Health and Human Services (HHS) cannot guarantee the accuracy of a non-federal website.
                  Linking to a non-federal website does not mean that HHS or its employees endorse the sponsors, information, or products presented on the website. HHS links outside of itself to provide you with further information.
                  You will be bound by the destination website's privacy policy and/or terms of service when you follow the link.
                  HHS is not responsible for Section 508 compliance (accessibility) on private websites.For more information on HHS's web notification policies, see Website Disclaimers.
              Continue
                  Go back